Standardized sTudy With Almotriptan in eaRly Treatment of Migraine, START. An International, Open-Label, Single Arm, Effectiveness and Safety Study of Almotriptan in Primary Care Setting.

Trial Profile

Standardized sTudy With Almotriptan in eaRly Treatment of Migraine, START. An International, Open-Label, Single Arm, Effectiveness and Safety Study of Almotriptan in Primary Care Setting.

Completed
Phase of Trial: Phase IV

Latest Information Update: 11 Jun 2015

At a glance

  • Drugs Almotriptan (Primary)
  • Indications Migraine
  • Focus Therapeutic Use
  • Acronyms START
  • Sponsors Almirall S.A.
  • Most Recent Events

    • 24 Mar 2012 This trial has recruiting in France.
    • 09 Oct 2009 Actual end date (Jul 2009) added as reported by ClinicalTrials.gov.
    • 09 Oct 2009 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top